Screening for potential quality markers of Callerya nitida var. hirsutissima. Z.Wei based on components profile, pharmacokinetics, and anti-inflammatory study
- PMID: 34729921
- DOI: 10.1002/jssc.202100543
Screening for potential quality markers of Callerya nitida var. hirsutissima. Z.Wei based on components profile, pharmacokinetics, and anti-inflammatory study
Abstract
Callerya nitida var. hirsutissima. Z.Wei is a classical, traditional Chinese herbal medicine mostly used to treat rheumatoid arthritis. Recent reports suggest that inconsistent and poor-quality control levels have primarily affected the therapeutic efficacy. Therefore, the aim of the current study was to investigate the active chemical ingredients, stability of components in blood, pharmacokinetics, and pharmacodynamics to specify the potential markers for quality control and quality evaluation of Callerya nitida. The active components in vitro and in vivo were obtained by ultra-high-performance liquid chromatography-mass spectrometry. Moreover, the changes of the bioactive components in the blood were monitored over time (0-24 h) in order to identify stable active components. On this basis, the pharmacokinetic characteristics of these ingredients combined with the anti-inflammatory activity were determined to screen out the potential markers for ensuring the quality control of Callerya nitida. The identified four components, such as calycosin, daidzein, formononetin, and 5-hydroxymethylfurfural, have the characteristics of intrinsic components, clearly defined structures, high exposure values, and in vivo stability, which are important for the therapeutic activity of pharmacologically active materials. Therefore, they can be used as potential markers to control the quality levels of Callerya nitida.
Keywords: mass spectrometry; pharmacokinetics; quality markers; traditional Chinese medicine; ultra high performance liquid chromatography.
© 2021 Wiley-VCH GmbH.
References
REFERENCES
-
- Liu CX, Cheng YY, Guo DA, Zhang TJ, Li YZ, Hou WB, Zhang TJ, Li YZ, Hou WB, Huang LQ. A new concept on quality marker for quality assessment and process control of chinese medicines. Chin Herb Med. 2017;009:3-13.
-
- Kang TG, Dou DQ, Xu L. Establishment of a quality marker (Q-marker) system for Chinese herbal medicines using burdock as an example. Phytomedicine 2019;54:339-46.
-
- Gong T, Wang DX, Chen RY, Ping L, Yu DQ. Novel benzil and isoflavone derivatives from millettia dielsiana. Planta Med. 2019;75:236-42.
-
- Xiang C, Cheng J, Liang H, Zhao YY, Feng J. Isoflavones from millettia nitida var. hirsutissima. Acta Pharmaceutica Sinica B. 2009;44:158-61.
-
- Zhang L, Liu YL, Rao ZJ, Li WB, Du P. Protection effects of millettia nitida benth.var.hirsutissima z.wei on hematopoietic system of mice. Chin J Mod Appl Pharm. 2009;26:349-53.
MeSH terms
Substances
Grants and funding
- GJJ181579/Science and Technology Key Project of Jiangxi Provincial Department of Education
- GJJ201206/Science and Technology Key Project of Jiangxi Provincial Department of Education
- 82074014/National Natural Science Foundation of China
- 82060808/National Natural Science Foundation of China
- 81960697/National Natural Science Foundation of China
- 20202BABL206142/Jiangxi Province Nature Scientific Project
- 20202BAB206079/Jiangxi Province Nature Scientific Project
- 2020Z003/Science and technology project of Jiangxi Administration of Traditional Chinese Medicine
- 202010412204/Innovation and entrepreneurship training program for College Students
- 202110412088/Innovation and entrepreneurship training program for College Students
- JZYC20S01/Jiangxi University of Traditional Chinese Medicine Graduate innovation Fund
LinkOut - more resources
Full Text Sources
